UniProt ID | GSHR_HUMAN | |
---|---|---|
UniProt AC | P00390 | |
Protein Name | Glutathione reductase, mitochondrial | |
Gene Name | GSR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 522 | |
Subcellular Localization |
Isoform Mitochondrial: Mitochondrion. Isoform Cytoplasmic: Cytoplasm. |
|
Protein Description | Maintains high levels of reduced glutathione in the cytosol.. | |
Protein Sequence | MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | LSAGAGPSWRRAARA HHCCCCHHHHHHHHH | 32.09 | 26091039 | |
65 | Phosphorylation | AAGAVASYDYLVIGG CCCEEEECEEEEECC | 10.00 | 22817900 | |
97 | Acetylation | AAVVESHKLGGTCVN EEEEEHHHCCCEEEE | 59.09 | 23749302 | |
97 | Ubiquitination | AAVVESHKLGGTCVN EEEEEHHHCCCEEEE | 59.09 | - | |
101 | Phosphorylation | ESHKLGGTCVNVGCV EHHHCCCEEEECCCE | 16.10 | 29970186 | |
107 | Glutathionylation | GTCVNVGCVPKKVMW CEEEECCCEECEEEC | 4.05 | 22555962 | |
107 | S-nitrosylation | GTCVNVGCVPKKVMW CEEEECCCEECEEEC | 4.05 | 25040305 | |
110 | Acetylation | VNVGCVPKKVMWNTA EECCCEECEEECCCC | 37.29 | 129591 | |
110 | 2-Hydroxyisobutyrylation | VNVGCVPKKVMWNTA EECCCEECEEECCCC | 37.29 | - | |
111 | Ubiquitination | NVGCVPKKVMWNTAV ECCCEECEEECCCCC | 31.11 | - | |
137 | Acetylation | GFPSCEGKFNWRVIK CCCCCCCCEEEEEEH | 17.15 | 25953088 | |
138 (in isoform 2) | Ubiquitination | - | 18.23 | 21890473 | |
146 (in isoform 2) | Ubiquitination | - | 51.05 | 21890473 | |
150 | Nitration | IKEKRDAYVSRLNAI EHHHHHHHHHHHHHH | 11.84 | - | |
158 | Phosphorylation | VSRLNAIYQNNLTKS HHHHHHHHHCCCCHH | 11.63 | 28152594 | |
158 | Nitration | VSRLNAIYQNNLTKS HHHHHHHHHCCCCHH | 11.63 | - | |
163 | Phosphorylation | AIYQNNLTKSHIEII HHHHCCCCHHHEEEE | 32.40 | 28152594 | |
164 | Acetylation | IYQNNLTKSHIEIIR HHHCCCCHHHEEEEE | 43.11 | 23749302 | |
164 | Ubiquitination | IYQNNLTKSHIEIIR HHHCCCCHHHEEEEE | 43.11 | - | |
164 | 2-Hydroxyisobutyrylation | IYQNNLTKSHIEIIR HHHCCCCHHHEEEEE | 43.11 | - | |
165 | Phosphorylation | YQNNLTKSHIEIIRG HHCCCCHHHEEEEEC | 25.18 | 24247654 | |
177 | Phosphorylation | IRGHAAFTSDPKPTI EECCCCCCCCCCCEE | 27.74 | 26657352 | |
178 | Phosphorylation | RGHAAFTSDPKPTIE ECCCCCCCCCCCEEE | 45.52 | 20873877 | |
181 | Ubiquitination | AAFTSDPKPTIEVSG CCCCCCCCCEEEECC | 60.84 | 21890473 | |
181 | 2-Hydroxyisobutyrylation | AAFTSDPKPTIEVSG CCCCCCCCCEEEECC | 60.84 | - | |
181 | Ubiquitination | AAFTSDPKPTIEVSG CCCCCCCCCEEEECC | 60.84 | 21890473 | |
181 | Ubiquitination | AAFTSDPKPTIEVSG CCCCCCCCCEEEECC | 60.84 | 21890473 | |
181 | Ubiquitination | AAFTSDPKPTIEVSG CCCCCCCCCEEEECC | 60.84 | 21890473 | |
181 (in isoform 1) | Ubiquitination | - | 60.84 | 21890473 | |
183 | Phosphorylation | FTSDPKPTIEVSGKK CCCCCCCEEEECCEE | 35.58 | 20873877 | |
187 | Phosphorylation | PKPTIEVSGKKYTAP CCCEEEECCEEEECC | 31.91 | 20873877 | |
189 | Acetylation | PTIEVSGKKYTAPHI CEEEECCEEEECCEE | 34.79 | 7669677 | |
189 | Ubiquitination | PTIEVSGKKYTAPHI CEEEECCEEEECCEE | 34.79 | 1890473 | |
189 | 2-Hydroxyisobutyrylation | PTIEVSGKKYTAPHI CEEEECCEEEECCEE | 34.79 | - | |
189 (in isoform 1) | Ubiquitination | - | 34.79 | 21890473 | |
190 | Acetylation | TIEVSGKKYTAPHIL EEEECCEEEECCEEE | 51.89 | 7672053 | |
257 (in isoform 2) | Ubiquitination | - | 28.88 | 21890473 | |
278 | Glutathionylation | DSMISTNCTEELENA HHHHCCCCHHHHHHC | 5.26 | 22555962 | |
278 | S-nitrosylation | DSMISTNCTEELENA HHHHCCCCHHHHHHC | 5.26 | 25040305 | |
291 | Ubiquitination | NAGVEVLKFSQVKEV HCCCEEEEHHHHHHH | 48.41 | - | |
296 | Ubiquitination | VLKFSQVKEVKKTLS EEEHHHHHHHHHHHC | 49.50 | - | |
296 | 2-Hydroxyisobutyrylation | VLKFSQVKEVKKTLS EEEHHHHHHHHHHHC | 49.50 | - | |
296 | Acetylation | VLKFSQVKEVKKTLS EEEHHHHHHHHHHHC | 49.50 | 25953088 | |
297 (in isoform 2) | Ubiquitination | - | 61.79 | 21890473 | |
300 | Ubiquitination | SQVKEVKKTLSGLEV HHHHHHHHHHCCCEE | 60.93 | 21890473 | |
300 (in isoform 1) | Ubiquitination | - | 60.93 | 21890473 | |
301 | Phosphorylation | QVKEVKKTLSGLEVS HHHHHHHHHCCCEEE | 22.05 | 28857561 | |
303 | Phosphorylation | KEVKKTLSGLEVSMV HHHHHHHCCCEEEEE | 46.71 | 28857561 | |
303 (in isoform 2) | Ubiquitination | - | 46.71 | 21890473 | |
308 | Phosphorylation | TLSGLEVSMVTAVPG HHCCCEEEEEEECCC | 9.73 | - | |
319 | Acetylation | AVPGRLPVMTMIPDV ECCCCCCEEEEECCH | 6.21 | 19608861 | |
340 | Ubiquitination | IGRVPNTKDLSLNKL HCCCCCCCCCCCHHC | 64.41 | 21906983 | |
340 (in isoform 1) | Ubiquitination | - | 64.41 | 21890473 | |
346 | Ubiquitination | TKDLSLNKLGIQTDD CCCCCCHHCCEECCC | 54.08 | 21906983 | |
346 (in isoform 1) | Ubiquitination | - | 54.08 | 21890473 | |
348 | Acetylation | DLSLNKLGIQTDDKG CCCCHHCCEECCCCC | 16.15 | 19608861 | |
354 | Ubiquitination | LGIQTDDKGHIIVDE CCEECCCCCCEEEEC | 56.02 | - | |
354 | Acetylation | LGIQTDDKGHIIVDE CCEECCCCCCEEEEC | 56.02 | 25038526 | |
362 (in isoform 2) | Ubiquitination | - | 6.17 | 21890473 | |
368 | Ubiquitination | EFQNTNVKGIYAVGD CCCCCCCCCEEEEEC | 41.48 | - | |
371 | Phosphorylation | NTNVKGIYAVGDVCG CCCCCCEEEEECCCC | 12.14 | 28152594 | |
372 | Acetylation | TNVKGIYAVGDVCGK CCCCCEEEEECCCCH | 9.26 | 19608861 | |
374 | Ubiquitination | VKGIYAVGDVCGKAL CCCEEEEECCCCHHH | 17.29 | 21890473 | |
377 | Glutathionylation | IYAVGDVCGKALLTP EEEEECCCCHHHHHH | 5.72 | 22555962 | |
377 | S-nitrosylation | IYAVGDVCGKALLTP EEEEECCCCHHHHHH | 5.72 | 25040305 | |
379 | Ubiquitination | AVGDVCGKALLTPVA EEECCCCHHHHHHHH | 30.63 | - | |
383 | Phosphorylation | VCGKALLTPVAIAAG CCCHHHHHHHHHHHH | 19.30 | 29255136 | |
398 (in isoform 2) | Ubiquitination | - | 10.99 | 21890473 | |
401 | Acetylation | AHRLFEYKEDSKLDY HHHHHCCCCCCCCCC | 48.09 | 19608861 | |
401 | Ubiquitination | AHRLFEYKEDSKLDY HHHHHCCCCCCCCCC | 48.09 | 19608861 | |
401 | 2-Hydroxyisobutyrylation | AHRLFEYKEDSKLDY HHHHHCCCCCCCCCC | 48.09 | - | |
403 | Ubiquitination | RLFEYKEDSKLDYNN HHHCCCCCCCCCCCC | 47.09 | 21890473 | |
405 | Ubiquitination | FEYKEDSKLDYNNIP HCCCCCCCCCCCCCC | 58.67 | 21906983 | |
405 | 2-Hydroxyisobutyrylation | FEYKEDSKLDYNNIP HCCCCCCCCCCCCCC | 58.67 | - | |
405 (in isoform 1) | Ubiquitination | - | 58.67 | 21890473 | |
408 | Phosphorylation | KEDSKLDYNNIPTVV CCCCCCCCCCCCEEE | 22.12 | 22817900 | |
413 (in isoform 2) | Ubiquitination | - | 26.04 | 21890473 | |
427 | Phosphorylation | PIGTVGLTEDEAIHK CCCCCCCCCCHHHHH | 35.15 | - | |
427 | Ubiquitination | PIGTVGLTEDEAIHK CCCCCCCCCCHHHHH | 35.15 | 21890473 | |
434 | Ubiquitination | TEDEAIHKYGIENVK CCCHHHHHHCCCCCE | 38.77 | - | |
434 | Acetylation | TEDEAIHKYGIENVK CCCHHHHHHCCCCCE | 38.77 | 25038526 | |
441 | Ubiquitination | KYGIENVKTYSTSFT HHCCCCCEEEECCCC | 54.01 | 21906983 | |
441 (in isoform 1) | Ubiquitination | - | 54.01 | 21890473 | |
442 | Phosphorylation | YGIENVKTYSTSFTP HCCCCCEEEECCCCH | 20.58 | 21945579 | |
443 | Phosphorylation | GIENVKTYSTSFTPM CCCCCEEEECCCCHH | 12.30 | 21945579 | |
444 | Phosphorylation | IENVKTYSTSFTPMY CCCCEEEECCCCHHH | 23.86 | 21945579 | |
445 | Phosphorylation | ENVKTYSTSFTPMYH CCCEEEECCCCHHHH | 19.90 | 21945579 | |
446 | Phosphorylation | NVKTYSTSFTPMYHA CCEEEECCCCHHHHH | 22.60 | 21945579 | |
448 | Phosphorylation | KTYSTSFTPMYHAVT EEEECCCCHHHHHHC | 13.60 | 21945579 | |
451 | Phosphorylation | STSFTPMYHAVTKRK ECCCCHHHHHHCCCC | 6.45 | 21945579 | |
455 | Phosphorylation | TPMYHAVTKRKTKCV CHHHHHHCCCCCHHH | 26.39 | 21945579 | |
456 | Acetylation | PMYHAVTKRKTKCVM HHHHHHCCCCCHHHE | 45.35 | 25953088 | |
456 | Ubiquitination | PMYHAVTKRKTKCVM HHHHHHCCCCCHHHE | 45.35 | 21890473 | |
456 | 2-Hydroxyisobutyrylation | PMYHAVTKRKTKCVM HHHHHHCCCCCHHHE | 45.35 | - | |
456 | Malonylation | PMYHAVTKRKTKCVM HHHHHHCCCCCHHHE | 45.35 | 26320211 | |
456 (in isoform 1) | Ubiquitination | - | 45.35 | 21890473 | |
458 (in isoform 2) | Ubiquitination | - | 54.62 | 21890473 | |
464 | Ubiquitination | RKTKCVMKMVCANKE CCCHHHEEEEECCCC | 14.05 | - | |
464 | Acetylation | RKTKCVMKMVCANKE CCCHHHEEEEECCCC | 14.05 | 26051181 | |
470 | Acetylation | MKMVCANKEEKVVGI EEEEECCCCCEEEEE | 49.04 | 25953088 | |
470 | Ubiquitination | MKMVCANKEEKVVGI EEEEECCCCCEEEEE | 49.04 | - | |
470 | 2-Hydroxyisobutyrylation | MKMVCANKEEKVVGI EEEEECCCCCEEEEE | 49.04 | - | |
484 | S-nitrosylation | IHMQGLGCDEMLQGF EEECCCCHHHHHHHH | 4.88 | 25040305 | |
501 | Ubiquitination | AVKMGATKADFDNTV HHHHCCCHHCCCCCE | 45.48 | 2190698 | |
501 (in isoform 1) | Ubiquitination | - | 45.48 | 21890473 | |
507 | Phosphorylation | TKADFDNTVAIHPTS CHHCCCCCEEECCCC | 17.10 | 28450419 | |
513 | Phosphorylation | NTVAIHPTSSEELVT CCEEECCCCCCHHEE | 30.62 | 28450419 | |
514 | Phosphorylation | TVAIHPTSSEELVTL CEEECCCCCCHHEEC | 39.96 | 28450419 | |
515 | Phosphorylation | VAIHPTSSEELVTLR EEECCCCCCHHEECC | 37.25 | 28450419 | |
520 | Phosphorylation | TSSEELVTLR----- CCCCHHEECC----- | 29.46 | 28450419 | |
522 | Methylation | SEELVTLR------- CCHHEECC------- | 34.82 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
507 | T | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GSHR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GSHR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PJA1_HUMAN | PJA1 | physical | 16169070 | |
GSHR_HUMAN | GSR | physical | 9151953 | |
PURA2_HUMAN | ADSS | physical | 22863883 | |
CNDP2_HUMAN | CNDP2 | physical | 22863883 | |
DX39A_HUMAN | DDX39A | physical | 22863883 | |
EF2_HUMAN | EEF2 | physical | 22863883 | |
GBP2_HUMAN | GBP2 | physical | 22863883 | |
PSF2_HUMAN | GINS2 | physical | 22863883 | |
CH60_HUMAN | HSPD1 | physical | 22863883 | |
KYNU_HUMAN | KYNU | physical | 22863883 | |
MVD1_HUMAN | MVD | physical | 22863883 | |
NAMPT_HUMAN | NAMPT | physical | 22863883 | |
PEPD_HUMAN | PEPD | physical | 22863883 | |
KS6A1_HUMAN | RPS6KA1 | physical | 22863883 | |
AIFM1_HUMAN | AIFM1 | physical | 26344197 | |
ASSY_HUMAN | ASS1 | physical | 26344197 | |
LSM12_HUMAN | LSM12 | physical | 26344197 | |
TOM40_HUMAN | TOMM40 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-65, AND MASSSPECTROMETRY. |